Lyell Immunopharma, Inc. (LYEL)
12.09
-0.79
(-6.13%)
USD |
NASDAQ |
Sep 10, 14:18
Lyell Immunopharma 1 Year Total Returns (Daily) : -2.05% for Sept. 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 09, 2026 | -2.05% |
| September 08, 2026 | 3.84% |
| September 04, 2026 | 22.61% |
| September 03, 2026 | 25.28% |
| September 02, 2026 | 31.07% |
| September 01, 2026 | 31.09% |
| August 31, 2026 | 29.24% |
| August 28, 2026 | 30.90% |
| August 27, 2026 | 29.52% |
| August 26, 2026 | 35.04% |
| August 25, 2026 | 41.20% |
| August 24, 2026 | 36.99% |
| August 21, 2026 | 45.82% |
| August 20, 2026 | 44.13% |
| August 19, 2026 | 45.52% |
| August 18, 2026 | 45.06% |
| August 17, 2026 | 28.07% |
| August 14, 2026 | 29.65% |
| August 13, 2026 | 26.87% |
| August 12, 2026 | 34.06% |
| August 11, 2026 | 40.64% |
| August 10, 2026 | 30.51% |
| August 07, 2026 | 29.95% |
| August 06, 2026 | 28.25% |
| August 05, 2026 | 17.67% |
| Date | Value |
|---|---|
| August 04, 2026 | 19.61% |
| August 03, 2026 | 16.79% |
| July 31, 2026 | 9.57% |
| July 30, 2026 | 10.29% |
| July 29, 2026 | 0.78% |
| July 28, 2026 | -5.39% |
| July 27, 2026 | 4.35% |
| July 24, 2026 | 21.33% |
| July 23, 2026 | 16.29% |
| July 22, 2026 | 24.90% |
| July 21, 2026 | 38.15% |
| July 20, 2026 | 39.83% |
| July 17, 2026 | 39.92% |
| July 16, 2026 | 45.75% |
| July 15, 2026 | 56.70% |
| July 14, 2026 | 38.57% |
| July 13, 2026 | 46.97% |
| July 10, 2026 | 53.63% |
| July 09, 2026 | 48.97% |
| July 08, 2026 | 64.97% |
| July 07, 2026 | 73.88% |
| July 06, 2026 | 44.89% |
| July 02, 2026 | 48.99% |
| July 01, 2026 | 37.61% |
| June 30, 2026 | 58.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 198.0% |
| Oncolytics Biotech, Inc. | -42.81% |
| Sangamo Therapeutics, Inc. | -70.18% |
| Sarepta Therapeutics, Inc. | 24.83% |
| Anixa Biosciences, Inc. | -5.03% |